
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $12M | $11.8M | $54.5M | $29.1M | $27.1M | |
Revenue Growth (YoY) | -41.25% | -1.99% | 361.16% | -46.58% | -6.81% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1M | $1.1M | $922.4K | $1.1M | $1.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.1M | $1.1M | $922.4K | $1.1M | $1.7M | |
Operating Income | $11M | $10.7M | $53.5M | $28M | $25.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $11M | $10.7M | $53.5M | $28M | $25.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $11M | $10.7M | $53.5M | $28M | $25.4M | |
Basic EPS (Cont. Ops) | $0.24 | $0.23 | $1.15 | $0.60 | $0.55 | |
Diluted EPS (Cont. Ops) | $0.24 | $0.23 | $1.15 | $0.60 | $0.55 | |
Weighted Average Basic Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
Weighted Average Diluted Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
EBITDA | $11M | $10.7M | $53.5M | $28M | $25.4M | |
EBIT | $11M | $10.7M | $53.5M | $28M | $25.4M | |
Revenue (Reported) | $12M | $11.8M | $54.5M | $29.1M | $27.1M | |
Operating Income (Reported) | $11M | $10.7M | $53.5M | $28M | $25.4M | |
Operating Income (Adjusted) | $11M | $10.7M | $53.5M | $28M | $25.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.1M | $4.1M | $5.2M | $6M | $3.1M | |
Revenue Growth (YoY) | -66.04% | 91.95% | 27.96% | 15.78% | -49.19% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $285.7K | $345.2K | $480.1K | $552.5K | $475K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $285.7K | $345.2K | $480.1K | $552.5K | $475K | |
Operating Income | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Basic EPS (Cont. Ops) | $0.04 | $0.08 | $0.10 | $0.12 | $0.06 | |
Diluted EPS (Cont. Ops) | $0.04 | $0.08 | $0.10 | $0.12 | $0.06 | |
Weighted Average Basic Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
Weighted Average Diluted Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
EBITDA | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
EBIT | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Revenue (Reported) | $2.1M | $4.1M | $5.2M | $6M | $3.1M | |
Operating Income (Reported) | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Operating Income (Adjusted) | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.9M | $13.8M | $55.6M | $29.9M | $24.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $998.5K | $1.1M | $1.1M | $1.2M | $1.6M | |
Other Inc / (Exp) | -$50K | -- | -- | -- | -- | |
Operating Expenses | $998.5K | $1.1M | $1.1M | $1.2M | $1.6M | |
Operating Income | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
Basic EPS (Cont. Ops) | $0.15 | $0.27 | $1.17 | $0.62 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.15 | $0.27 | $1.17 | $0.62 | $0.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
EBIT | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
Revenue (Reported) | $7.9M | $13.8M | $55.6M | $29.9M | $24.1M | |
Operating Income (Reported) | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M | |
Operating Income (Adjusted) | $6.9M | $12.6M | $54.5M | $28.7M | $22.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.1M | $4.1M | $5.2M | $6M | $3.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $285.7K | $345.2K | $480.1K | $552.5K | $475K | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $285.7K | $345.2K | $480.1K | $552.5K | $475K | |
Operating Income | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Basic EPS (Cont. Ops) | $0.04 | $0.08 | $0.10 | $0.12 | $0.06 | |
Diluted EPS (Cont. Ops) | $0.04 | $0.08 | $0.10 | $0.12 | $0.06 | |
Weighted Average Basic Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
Weighted Average Diluted Share | $46.6M | $46.6M | $46.6M | $46.6M | $46.6M | |
EBITDA | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
EBIT | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Revenue (Reported) | $2.1M | $4.1M | $5.2M | $6M | $3.1M | |
Operating Income (Reported) | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M | |
Operating Income (Adjusted) | $1.8M | $3.7M | $4.7M | $5.5M | $2.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | -- | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.7M | $2.2M | $2.9M | $6.1M | $2.1M | |
Property Plant And Equipment | $382.9K | $352.7K | $279.4K | $221.5K | $164.4K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.1M | $2.6M | $3.1M | $6.3M | $2.3M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $625.5K | $1.1M | $1.8M | $5M | $1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7M | $2.2M | $2.9M | $6.1M | $2.1M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $382.9K | $352.7K | $279.4K | $221.5K | $164.4K | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $382.9K | $352.7K | $279.4K | $221.5K | $164.4K | |
Total Liabilities and Equity | $2.1M | $2.6M | $3.1M | $6.3M | $2.3M | |
Cash and Short Terms | $1.7M | $2.2M | $2.9M | $6.1M | $2.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | -- | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.6M | $2M | $2.2M | $3M | $1.9M | |
Property Plant And Equipment | $373.1K | $336.6K | $239.4K | $209.6K | $163.8K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2M | $2.3M | $2.4M | $3.2M | $2.1M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $537.5K | $902.7K | $1.1M | $1.9M | $848.6K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6M | $2M | $2.2M | $3M | $1.9M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $373.1K | $336.6K | $239.4K | $209.6K | $163.8K | |
Total Liabilities and Equity | $2M | $2.3M | $2.4M | $3.2M | $2.1M | |
Cash and Short Terms | $1.6M | $2M | $2.2M | $3M | $1.9M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2004-12-31 | 2005-12-31 | 2006-12-31 | 2007-12-31 | 2008-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $44.5M | $62.3M | $65.7M | $67.6M | $111.5M | |
Depreciation & Amoritzation | -- | -- | $171.4K | $145.3K | $123.1K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $44.4M | $63.4M | $65.5M | $67.5M | $111.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$44.5M | -$62.3M | -$65.7M | -$67.6M | -$111.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$44.5M | -$62.3M | -$65.7M | -$67.6M | -$111.5M | |
Beginning Cash (CF) | $2M | $6.1M | $1.6M | $1.4M | $1.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$196.3K | $1.2M | -$171.4K | -$145.3K | -$123.1K | |
Ending Cash (CF) | $1.8M | $7.3M | $1.4M | $1.3M | $1.2M | |
Levered Free Cash Flow | $44.4M | $63.4M | $65.5M | $67.5M | $111.3M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.